Treatment Sessions

Treatment Sessions Based on an individual's condition and symptoms, this can vary, since like many wellness and health regimens, individuals respond differently.

Many individuals will notice a positive effect in just in one session, however, a series of sessions is recommended for optimal results. Some people go two to three times a week for a three to four-week ritual during allergy and cold seasons, some people go twice a week for six to eight weeks for more chronic conditions.

Those who go for general wellness, stress relief, and relaxation simply go as often as they like. For best results, a series of treatments is recommended.

The Salt Therapy Association additionally recommends using dry salt therapy as a continuous preventive measure to strengthen the immune system against colds, cough, allergies, and sinusitis. There are some people who have salt therapy in their homes and do a daily ritual. You cannot overdose from salt therapy.

European countries have incorporated the following duration of treatment:

• Asthma (mild): 12-14 days

• Asthma (severe): 18-21 days

• Acute bronchitis: 12-14 days

• Recurrent bronchitis: 12-14 days

• Chronic simple bronchitis: 18-21 days

• Chronic obstructive bronchitis: 18-21 days

• Pneumonia after acute stage: 12-14 days

• Cystic fibrosis: 20-25 days

• Chronic sinusitis: 14-18 days

• Acute sinusitis: 3-5 days

• Hay fever: 12-14 days

• Smokers: 12-14 days

please note:

For best results, during a course of therapy, chronic sufferers should try to complete sessions as consecutively as possible - daily is best, but at least 3 times a week are usually needed for challenging cases. Back-to-back sessions - two in a row - can be greatly beneficial for sinus and skin conditions, though are not always recommended for chronic lung conditions.

source:

MINISTRY OF PUBLIC HEALTH OF THE RUSSIAN FEDERATION, Halotherapy Application in Treatment and Rehabilitation of Respiratory Diseases,

Methodical Recommendation No. 95/111, Moscow 1995 Methodical recommendation was discussed and approved by the Scientific Board of the Institute of Pulmonology of the Russian Federation.

Clinical-Research Respiratory Center, St. Petersburg – Doctors A.V. Chervinskaya, S.I. Konovalov, O.V. Strashnova, N.G. Samsonova

Institute of Pulmonology of the Russian Federation, Moscow – Doctors A.G. Chchalin, I.D. Apulcina, I.E. Furman, A.A. Bondarenko, M.V. Samsonova

Pavlov National Medical University, St. Petersburg – Doctors M.S. Pluzhnikov, A.N. Aleksandrov, I.M. Raznatovskiy, N.N. Tretyakova, K.N. Monachov